awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37655585-9B3B2123-519D-4E77-BB0F-404BCA1F60FF
Q37655585-9B3B2123-519D-4E77-BB0F-404BCA1F60FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37655585-9B3B2123-519D-4E77-BB0F-404BCA1F60FF
State of the art in anti-cancer mAbs.
P2860
Q37655585-9B3B2123-519D-4E77-BB0F-404BCA1F60FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37655585-9B3B2123-519D-4E77-BB0F-404BCA1F60FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df9a472c89651a766fa60221ef498f68907f7925
P2860
Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.